Moreover, it was demonstrated that the treatment with anti-PK2 antibodies was effective in reducing tumor growth and angiogenesis and exerted an additive antitumor effect in combination with anti-Vegf agents or cisplatin [61]. This evidence concerns the gene VEGFA and neoplasm.